One new pyrrolosesquiterpene 1 was isolated from cultures of the soil actinomycete Streptomyces sp. Hd7-21. Its structure was elucidated by extensive MS and 1D and 2D NMR spectroscopic data analyses.
Natural products play an important role in drug discovery and have been used for the treatment of diseases for decades [1] . Actinomycetes are widely distributed in nature, and are typically useful in the pharmaceutical industry for their seemingly unlimited capacity to produce secondary metabolites with diverse chemical structures and biological activities [2] . It is essential to continue searching for new antibiotics because of the toxicity of some currently used compounds and the emergence of resistant pathogens [3] . Streptomyces produce over 70% of the known antibiotics, and about 70% of all known medicines were isolated from actinomycetes bacteria of which 75% and 60% have been used in medicine and agriculture, respectively [4] [5] [6] .
Pyrroles have been incorporated into a variety of natural products, yet their apearance among terpenes are rare. To our knowledge, the only previously described pyrroloterpene natural products are pyrrolostatin [7] and glyciapyrroles A-C [8] . As part of our ongoing search for biologically active secondary metabolites, Streptomyces sp. Hd7-21 from soil sample collected in Daxinganling virgin forest came to our attention as it displayed an interesting chemical profile from our initial LC-MS analysis. This prompted us to investigate the chemical diversity of this strain, which led to the isolation of one new pyrrolosesquiterpene 1. We herein report the fermentation, isolation, structure elucidation and the biological activity of the compound. Since four of the carbons could be assigned to the pyrrole, the remaining 15 carbons were postulated to comprise a sesquiterpenoid side chain, which was further confirmed through a series of COSY and HMBC correlations ( Figure 1) . The cross-peaks between H-10 and H-9/H-11, and H-14 and H-13/H-15 were observed in the 1 H-1 H COSY spectrum. 13 C-1 H long-range couplings observed in the HMBC experiments gave the following correlations of H-20 with C-15, C-16, and C-17, of H-17 with C-15, C-16, and C-20, of H-13 with C-11 and C-12, of H-19 with C-11, C-12, and C-13, of H-18 with C-7, C-8, and C-9, and of H-9 with C-7, C-8, and C-18. By combining all this evidence and data, we were able to assign planar structure of the fragment 2,6,10-trimethyl-5,6,11-trihydroxyundecan-1,3,9-triene. The characterization of the sesquiterpenoid side chain was completed by joining the C-7/C-8 olefin to the ketone carbonyl through an HMBC correlation H-7/C-6. Although H-7 was not correlated to C-2 in the HMBC spectrum, a correlation was observed between H-3 and H-7 in the NOESY experiment, establishing the connectivity between the pyrrole and its sesquiterpene side chain. 
Extraction and isolation:
After fermentation, the culture (20 L) was centrifuged to yield supernatant and a mycelial cake. The supernatant was extracted with equal volumes of ethyl acetate three times, and then samples were evaporated to dryness. The mycelial cake was extracted with 1.5 L of acetone three times, and the solvent was then evaporated to dryness. The two organic extracts were finally combined to give 5.6 g of residue, which was subjected to column chromatography over silica gel (200-300 mesh) using gradient elution with a CHCl 3 −MeOH mixture (from 1:0 to 0:1) to afford fractions A-G. Fraction C was subjected to further column chromatography over silica gel, eluting with a gradient of EtOAc in petroleum ether (from 5:1 to 0:1), to give fractions C 1 -C 5. Subfraction C 3 was repeatedly chromatographed on a silica gel column eluted with CHCl 3 -MeOH (50:1-10:1) to afford compound 1 (18.6 mg). Antibacterial assay: Compound 1 was tested for antibacterial activity against a panel of bacteria [Staphylococcus aureus (ATCC6538), Bacillus thuringiensis (ATCC39765), and Bacillus subtilis (ATCC6633)]. MIC was determined using a dilution antibacterial susceptibility test for aerobic bacteria. Compound 1 was dissolved in DMSO, serially diluted to concentrations of 10.0-100.0 μg/mL, and tested in a 96-well plate in triplicate. Erythromycin was used as the positive control.
